InvestorsHub Logo
icon url

hschlauch

10/19/17 8:13 AM

#40323 RE: chickpea598 #40321

Take a close look at Epac plus pembro data for advanced melanoma. Those patients are all treatment naive! All the patients in the immunopulse plus pembro trial had prior treatments. This is a complete no brainier.